Related Experiment Video

Updated: Mar 19, 2026

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
04:07

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

Published on: February 24, 2023

2.4K

Inhibitory PARP w terapii raka jajnika

Maksymilian Artur Kruczała1, Aleksandra Grela-Wojewoda, Ida Cedrych

  • 1Centrum Onkologii Instytut im. Marii Skłodowskiej-Curie Oddział w Krakowie. Klinika Nowotworów Układowych i Uogólnionych.. m_kruczala@onet.pl.

Ginekologia Polska
|June 17, 2016
PubMed

Insights

Poly (ADP-ribose) polymerase (PARP) inhibitors offer new hope for treating ovarian cancer, particularly for relapsed cases. This review summarizes current knowledge on their effectiveness in ovarian cancer therapy.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Malignant ovarian tumors present significant treatment challenges due to late-stage detection and poor prognosis.
  • Recurrent ovarian cancer treatment options are often limited to palliative care.

Purpose of the Study:

  • To review the current knowledge and therapeutic applications of Poly (ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer.
  • To highlight the potential of PARP inhibitors in improving treatment outcomes for ovarian cancer patients.

Main Methods:

  • Literature review of existing studies on PARP inhibitors in ovarian cancer therapy.
  • Synthesis of current data on the efficacy and application of PARP inhibitors.

Main Results:

  • PARP inhibitors represent a promising advancement in ovarian cancer treatment.
  • These inhibitors offer potential for improved outcomes, especially in managing recurrent disease.

Conclusions:

  • PARP inhibitors are an evolving therapeutic strategy for ovarian cancer.
  • Further research and clinical application of PARP inhibitors are warranted to optimize ovarian cancer management.
Keywords:
PARP inhibitorsovarian cancertargeted therapy

More Related Videos

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.9K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.3K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
1